Isopropamide
|  | |
| Clinical data | |
|---|---|
| MedlinePlus | a694006 | 
| Routes of administration | Oral | 
| ATC code | A03AB09 (WHO) | 
| Legal status | |
| Legal status | 
 | 
| Identifiers | |
| 
 | |
| CAS Number | 7492-32-2  | 
| PubChem (CID) | 3775 | 
| DrugBank | DB01625  | 
| ChemSpider | 3643  | 
| UNII | 8B9I31H724  | 
| ChEMBL | CHEMBL1201232  | 
| ECHA InfoCard | 100.028.470 | 
| Chemical and physical data | |
| Formula | C23H33N2O+ | 
| Molar mass | 353.52092 g/mol | 
| 3D model (Jmol) | Interactive image | 
| 
 | |
| 
 | |
|   (what is this?)  (verify) | |
Isopropamide (R5) is a long-acting anticholinergic drug. It is used in the treatment of peptic ulcers and other gastrointestinal disorders involving hyperacidity (gastrointestinal acidosis) and hypermotility. Chemically, it contains a quaternary ammonium group. It is most often provided as an iodide salt, but is also available as a bromide or chloride salt. It was discovered at Janssen Pharmaceutica in 1954.
References
- Seeherman R, Isopropamide iodide: a long-acting anticholinergic, Del Med J. 1957 Oct;29(10):265-9.
- Boss EG Jr, Buchanan GC, Effect of isopropamide iodide on basal gastric secretion in the human, Gastroenterology. 1957 Nov;33(5):730-6.
This article is issued from Wikipedia - version of the 9/4/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.